Pritzker Levine To Be Recognized for Outstanding Antitrust Litigation Achievement by the American Antitrust Institute

October 12, 2022 – Pritzker Levine is pleased to announce that the firm will be honored by the American Antitrust Institute’s Antitrust Enforcement Awards for their work in In re EpiPen Marketing, Sales Practices and Antitrust Litigation. Pritzker Levine will be …

Pritzker Levine To Be Recognized for Outstanding Antitrust Litigation Achievement by the American Antitrust Institute Read More »

Final Approval of $264 Million Settlement with Mylan Defendants Granted in EpiPen Class Action, Resulting in Total Recovery of $609 Million for the Class

July 11, 2022 – Judge Daniel D. Crabtree has granted final approval to the $264 million settlement between Plaintiffs and the Mylan Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, finding the settlement to …

Final Approval of $264 Million Settlement with Mylan Defendants Granted in EpiPen Class Action, Resulting in Total Recovery of $609 Million for the Class Read More »